オンコセラピー・サイエンス(株)の貸借残高情報

主市場業種証券コード/EDINET英名称
東証GRT医薬品4564/E05363OncoTherapy Science,Inc.
公表日公表貸付残高前週比新規貸付成約高前週比借入残高前週比新規借入成約高前週比
2025/02/21日証協33,110,230株-3.75%12,426,584株+141.06%44,060,316株-0.59%1,979,200株+72.46%
2025/02/14日証協34,401,528株-2.91%5,155,000株-61.62%44,322,216株-1.67%1,147,600株-12.87%
2025/02/07日証協35,434,028株+4.89%13,432,600株+76.25%45,072,951株+1.68%1,317,100株-28.04%
2025/01/31日証協33,782,478株-0.85%7,621,390株-31.43%44,327,651株-1.82%1,830,400株+123.7%
2025/01/24日証協34,072,523株+1.35%11,115,000株+4.11%45,147,151株-0.88%818,222株-48.12%
2025/01/17日証協33,620,245株-0.21%10,676,275株+58.98%45,549,151株+2.33%1,577,200株-28.39%
2025/01/10日証協33,689,823株+0.21%6,715,362株+29.6%44,510,751株+1.15%2,202,424株+771.09%
2024/12/30日証協33,618,923株-0.83%5,181,578株-32.97%44,004,292株-0.57%252,835株-92.28%
2024/12/27日証協33,899,445株+3.76%7,730,592株-35.46%44,256,492株+12.05%3,274,722株-59.24%
2024/12/20日証協32,669,745株-2.45%11,977,584株+44.18%39,496,792株-9.36%8,034,500株+285.62%
2024/12/13日証協33,490,706株-4.29%8,307,476株-29.93%43,576,996株-1.69%2,083,522株+43.36%
2024/12/06日証協34,990,630株+8.17%11,855,583株-5.5%44,326,596株-0.17%1,453,300株-42.07%
2024/11/29日証協32,348,447株-11.96%12,546,089株+42.98%44,400,696株-1.61%2,508,600株+16.42%
2024/11/22日証協36,744,606株-0.26%8,774,504株-30.02%45,126,796株+0.25%2,154,700株-12.67%
2024/11/15日証協36,840,928株-0.99%12,538,800株+3116.87%45,013,496株+0.41%2,467,400株+222.7%
2024/11/08日証協37,207,645株+4.94%389,783株-96.37%44,829,196株-0.54%764,600株-59.77%
2024/11/01日証協35,457,700株-13.64%10,725,243株-26.44%45,072,296株-5.47%1,900,700株+30.05%
2024/10/25日証協41,059,692株-5.84%14,579,484株+84.32%47,679,896株-1.74%1,461,500株+9.83%
2024/10/18日証協43,607,692株+0.85%7,909,892株-46.4%48,523,196株+1.55%1,330,702株-68.54%

※株式分割は考慮していませんのでご注意ください。

Page Top